Both in Pharmaceuticals
Evolus vs Monopar Therapeutics
Over the past year EOLS returned +30.1% and MNPR returned +5.4%; their daily moves had a correlation of 0.17.
EOLS +30.1% MNPR +5.4%Growth of $1, one year, split-adjusted
| Metric | EOLS | MNPR |
|---|---|---|
| Price | $7.99 | $80.00 |
| Market cap | $527.7M | $537.0M |
| Today | +0.38% | −4.44% |
| 1 month | −10.0% | −28.5% |
| 6 months | +102.8% | +50.1% |
| Year to date | +20.2% | +22.5% |
| 1 year | +33.4% | +4.4% |
| Revenue growth (YoY) | +21.2% | — |
| Gross margin | 68.0% | — |
| Net margin | −9.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.7× | — |
| Net cash | -$141.9M | $134.3M |
| Dividend yield | — | — |
| Volatility (60d) | 60.7% | 58.8% |
| Short % of float | 10.5% | 17.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).